{
    "clinical_study": {
        "@rank": "114387", 
        "arm_group": [
            {
                "arm_group_label": "Patient controlled analgesia", 
                "description": "Use of patient controlled analgesia (PCA) for the management of postoperative pain after the Nuss procedure."
            }, 
            {
                "arm_group_label": "Continuous thoracic epidural infusion", 
                "description": "Continuous thoracic epidural infusions (TE) for the management of postoperative pain after the Nuss procedure."
            }, 
            {
                "arm_group_label": "Continuous paravertebral blockade", 
                "description": "Continuous paravertebral blockade (PVB) for the management of postoperative pain after the Nuss procedure."
            }
        ], 
        "brief_summary": {
            "textblock": "A retrospective chart review study analyzing the benefits of patient controlled analgesia,\n      thoracic epidural analgesia, and paravertebral nerve block catheters in patients having\n      surgical repair of pectus excavatum using the Nuss procedure."
        }, 
        "brief_title": "Nuss Procedure: Clinical Options in Pediatric Pain Management?", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pectus Excavatum", 
        "condition_browse": {
            "mesh_term": "Funnel Chest"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing the NUSS procedure since the beginning of 2011 to Sept. 30th,\n             2013.\n\n        Exclusion Criteria:\n\n          -  None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing the Nuss procedure to correct pectus excavatum at Nationwide\n        Children's Hospital."
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009267", 
            "org_study_id": "IRB13-00702"
        }, 
        "intervention": [
            {
                "arm_group_label": "Patient controlled analgesia", 
                "description": "A programable electronically controlled infusion pump that delivers an amount of intravenous analgesic when the patient presses a button.", 
                "intervention_name": "Patient controlled analgesia", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Continuous thoracic epidural infusion", 
                "description": "Continuous thoracic epidural infusions (TE) involves continuous infusion of drugs through a catheter placed into the epidural space, resulting in a loss of sensation\u2014including the sensation of pain\u2014by blocking the transmission of signals through nerve fibers in or near the spinal cord.", 
                "intervention_name": "Continuous thoracic epidural infusions", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Continuous paravertebral blockade", 
                "description": "Continuous paravertebral blockade (PVB) is the technique of injecting local anesthetic adjacent to the thoracic vertebra that anesthetizes the spinal nerve roots after they exit the spinal canal.", 
                "intervention_name": "Continuous paravertebral blockade", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43205"
                }, 
                "name": "Nationwide Children's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "overall_official": {
            "affiliation": "Nationwide Children's Hospital", 
            "last_name": "Beltran Ralph, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Total morphine dose will be evaluated in mg/kg/24 hour period, beginning with post-op day 0 until discharge from the hospital.", 
            "measure": "Total morphine dose", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009267"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nationwide Children's Hospital", 
            "investigator_full_name": "Ralph Beltran", 
            "investigator_title": "Assistant Clinical Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Pain scores obtained from the visual analog scale.", 
                "measure": "Pain score", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 3 days"
            }, 
            {
                "description": "Determine if there is a difference in length of hospitalization, and time to discharge.", 
                "measure": "Length of hospitalization", 
                "safety_issue": "No", 
                "time_frame": "Within the first week after surgery."
            }, 
            {
                "description": "Determine the incidence of nausea and vomiting measured by the postoperative ondansetron dosing, beginning with arrival to floor and up to the first 48 hrs of hospitalization.", 
                "measure": "Nausea and vomiting", 
                "safety_issue": "No", 
                "time_frame": "0-48 hrs. post-op"
            }
        ], 
        "source": "Nationwide Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ralph Beltran", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}